If you are not happy with the results below please do another search
Top U.S. infectious disease official Dr. Anthony Fauci said on Feb. 28 he was encouraging Americans to accept any of the three available Covid-19 vaccines, including the newly approved Johnson & Johnson shot.
The U.S. government on Feb. 27 authorized Johnson & Johnson’s single-dose Covid-19 vaccine, enabling millions more Americans to be vaccinated in the coming weeks and setting the vaccine up for additional approvals around the world.
President Joe Biden scored his first legislative win as the House of Representatives passed his $1.9 trillion coronavirus relief package early Feb. 27, though Democrats face challenges to their hopes of using the bill to raise the minimum wage.
Merck will have to wait to see if a Covid-19 therapeutic gained in November through the $425 million acquisition of OncoImmune can receive Emergency Use Authorization (EUA) after the U.S. Food and Drug Administration requested additional data beyond the Phase III study announced during 2020
A panel of expert advisers to the U.S. Food and Drug Administration on Feb. 26 voted in favor of authorizing Johnson & Johnson’s Covid-19 vaccine for emergency use, bringing it an important step closer to a U.S. rollout.
The head of the U.S. Centers for Disease Control and Prevention said on Feb. 26 that a recent decline in COVID-19 cases may be stalling, a development she described as concerning while urging that safeguards to fight the virus remain in place.
Countries seeking their own COVID-19 vaccine doses are making deals with drug companies that threaten the supply for the global COVAX program for poor and middle-income countries, the World Health Organization said on Feb. 26.
The U.S. Food and Drug Administration approved Sarepta Therapeutics’ Amondys 45 (casimersen) for patients with Duchenne muscular dystrophy (DMD) who have a confirmed mutation amenable to exon 45 skipping.
Researchers at Northwestern University identified a compound that appears to reverse the ongoing degeneration of upper motor neurons associated with amyotrophic lateral sclerosis (ALS).
A panel of expert advisers to the U.S. Food and Drug Administration began a meeting to discuss Johnson & Johnson’s one-dose COVID-19 vaccine on Friday, setting the stage for a possible emergency use authorization as early as this week.